Michael R Megna
CHIEF ACCOUNTING OFFICER · 3 filings · Latest: Apr 9, 2026
Kiniksa Pharmaceuticals International, plc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
KNSA | Michael R Megna | CHIEF ACCOUNTING OFFICER | Apr 9, 2026 | Sale | $46.69 | 6,625 | $309.3K | 27,418 | |
KNSA | Michael R Megna | CHIEF ACCOUNTING OFFICER | Apr 7, 2026 | Tax Withholding | $48.94 | 1,666 | $81.5K | 34,043 | |
KNSA | Michael R Megna | CHIEF ACCOUNTING OFFICER | Apr 7, 2026 | Option Exercise | $1.00 | 3,932 | $3.9K | 35,709 | |
KNSA | Michael R Megna | CHIEF ACCOUNTING OFFICER | Apr 1, 2026 | Tax Withholding | $48.13 | 3,205 | $154.3K | 31,777 | |
KNSA | Michael R Megna | CHIEF ACCOUNTING OFFICER | Apr 1, 2026 | Option Exercise | — | 7,564 | — | 34,982 | |
KNSA | Michael R Megna | CHIEF ACCOUNTING OFFICER | Jan 15, 2026 | Grant/Award | $24.16 | 372 | $9.0K | 27,418 |